2024-05-06 12:39:35
The revocation was made at the request of AstraZeneca itself: "At the holder's request, the marketing authorisation granted by Decision C(2021) 698(final) of 29 January 2021 for the medicinal product "Vaxzevria - COVID-19 Vaccine (ChAdOx1-S [recombinant])" is withdrawn." [Link] CURRENTLY_RATED_HELPFUL(12-3-7) Author
2024-05-07 18:44:15
NNN original posts states factual information. NEEDS_MORE_RATINGS(1-0-0) Author